Question 10260 — pharmacy and medications

Summary

Mr. Fabrice Barusseau draws the attention of the Minister of Labor, Health, Solidarity, Families, Autonomy and Disabled People to the supply tensions concerning the drugs Repatha and Praluent. Essential for certain patients suffering from severe cardiovascular pathologies, with no therapeutic alternative, these treatments make a decisive contribution to the prevention of accidents. cardiovascular. For several months, many hospital pharmacies and pharmacies have been reporting stock shortages and practitioners have even warned of a risk of these products being withdrawn from the French market. Such a situation would deprive many patients of essential treatment, with serious consequences for their health. He asks what measures the Government intends to take to guarantee continued availability of these drugs and avoid any risk of withdrawal from the market to the detriment of patients who depend on them and which the Government plans to ensure transparent information on the management of shortages.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.